Bioventix PLC Stock Price

AIM:BVXP Community·UK£114.9m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
13 Fair Values set on narratives written by author

Create a narrative

BVXP Share Price Performance

UK£0

-37.50 (-100.00%)

UK£0

-37.50 (-100.00%)

UK£0

Tue, 11 Nov 25

Share Pricen/a

BVXP Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

1 Risk

1 Reward

View Full Analysis

Bioventix PLC Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: 1.45
: 90.86%
: 57.83%
: 0%

View Full Analysis

About BVXP

Founded: 2003
Employees: 12
CEO: Peter Harrison
WebsiteView website: www.bioventix.com

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.